Andrew Liu
Otolaryngology · Cedar Rapids, IANPI 1871972695
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Med-el Corporation at 43.6% of the total. Reporting peaked in 2024 at $2,752 and has fallen 87.6% since, to $342 in 2025.
Across 48 payments — averaging $68.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Med-el Corporation$1K
- Inspire Medical Systems, Inc.$1K
- Cochlear Americas$238
- Sanofi$117
- Acclarent, Inc$106
- GSK$89
- plus $156 from 6 others
What the payments were for
- Travel & lodging$1,95559%
- Food & beverage$1,35041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Med-el Corporation | 8 | $1,440 |
| Inspire Medical Systems, Inc. | 12 | $1,159 |
| Cochlear Americas | 3 | $238 |
| Sanofi | 7 | $117 |
| Acclarent, Inc | 5 | $106 |
| GSK | 6 | $89 |
| Integra Lifesciences Corporation | 2 | $60 |
| Neurent Medical Limited | 1 | $29 |
| Amgen | 1 | $22 |
| Smith+Nephew | 1 | $19 |
| Advanced Bionics, LLC | 1 | $14 |
| Checkpoint Surgical, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,305 in reported general payments places this provider in the 80th percentile of 103 otolaryngology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 78 | $1,418 |
| Fluticasone Propionate | 94 | $1,004 |
| Ipratropium Bromide | 27 | $516 |
| Omeprazole | 64 | $364 |
| Mupirocin | 22 | $128 |
| Cephalexin | 25 | $106 |
| Ondansetron OdtOndansetron | 11 | $93 |
| Oxycodone Hcl | 25 | $75 |
| Prednisone | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Cedar Rapids
- Thomas HeinemanCedar Rapids$373K
- Madia RussilloCedar Rapids$4K
- Ryan DempewolfCedar Rapids$2K
- Jasmine HernandezCedar Rapids$776
- Bruce GantzIowa City$170K
- Nancy BaumanIowa City$31K
- Simon WrightWest Des Moines$21K
- Robert PettisOskaloosa$10K
- Brian AndrewsIowa City$9K
- Douglas HoisingtonWest Des Moines$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.